483
S.s.s. Company (international)S.s.s. Company (international) – FDA 483, Jun 26, 2026
Record Details
S.S.S. Company (international) in Atlanta, GA, an OTC drug manufacturer, was cited for significant deficiencies across its quality system. The inspection revealed failures in recalling out-of-specification products, inadequate process and equipment validations, deficient component and laboratory controls, and a lack of adherence to stability testing programs. These issues indicate a systemic breakdown in ensuring drug product quality, strength, and purity.
View Company Profile
ID · b5d76fab-3d6c-46e9-a3bf-7e233cb79a31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.